Metformin: Complete Patient Guide

What Is Metformin?

Metformin (brand names: Glucophage, Glumetza) lowers blood sugar by reducing glucose production in the liver and improving insulin sensitivity. It is almost always the first medication prescribed for type 2 diabetes.

Immediate-release vs extended-release: what's the difference

Metformin comes in two formulations. Immediate-release (IR) tablets release the drug quickly and are taken with meals; extended-release (XR) tablets release it slowly along the gut and are designed for once-daily dosing. Many people who get stomach upset on the immediate-release form tolerate the extended-release form better, which is worth raising with your doctor before concluding the drug doesn't suit you.

Strengths shown are the commonly marketed ones; the choice of formulation and strength is your doctor's decision, based on your blood sugar, kidney function and tolerance.

The B12 Problem Nobody Warns You About

Metformin interferes with how the last part of your small intestine takes up vitamin B12. The absorption step depends on calcium, and metformin disrupts it, so B12 crosses the gut wall less efficiently for as long as you keep taking the drug.² Your liver holds a large reserve, which is exactly why this is easy to miss: the stores absorb the shortfall for years before anything shows in your blood.

The long-term data are clear about the size of the effect. In the Diabetes Prevention Program Outcomes Study, participants were followed for over a decade on metformin or placebo. At five years, low B12 was roughly twice as common on metformin (4.3% against 2.3%), and low or borderline-low B12 affected 19.1% of the metformin group against 9.5% on placebo. Each additional year of metformin raised the odds of deficiency by about 13%.¹

The practical response is simple: have B12 checked periodically, and particularly once you have been taking metformin for several years, when liver stores are likely to be running down.² A few things speed that depletion, long-term acid-suppressing medicines, previous bariatric surgery, and older age. If your B12 sits at the borderline where the result is hard to interpret, methylmalonic acid and homocysteine can identify a true deficiency earlier than the B12 level alone.²

None of this is a reason to stop metformin, which remains a first-line drug for good reasons. It is a reason to add one test to your monitoring and to say something if your feet start to tingle, rather than assuming it is inevitable.

Blood Tests to Monitor on Metformin

Why the Stomach Side Effects Usually Pass

Most people starting metformin get some diarrhoea, nausea or cramping, and most find it settles over a few weeks. This is why doses are started low and stepped up slowly rather than begun at the target dose: the titration exists to give your gut time to adapt, not to check whether the drug is working.

If symptoms persist, three things help before anyone concludes the drug is intolerable. Taking it with food rather than on an empty stomach reduces the effect substantially. Going back to the previous dose for a few weeks and then climbing more gradually often succeeds where a rapid increase failed. And a modified-release form releases the drug more slowly along the gut, which many people tolerate when standard tablets defeat them. Say so before abandoning the drug, because the alternative is usually a medicine with more to answer for.

Common Side Effects

• Nausea, stomach upset (most common, usually improves after 2–4 weeks)
• Diarrhoea especially when starting
• Metallic taste
• Loss of appetite
• Vitamin B12 deficiency with long-term use

Starting metformin: what to do next

Metformin is usually a long-term medicine, so the first few conversations with your doctor matter. Use this as a checklist, not as medical advice:

When Metformin Must Be Stopped

Metformin and Weight Loss

Metformin often causes modest weight loss (1–3 kg) as a side effect, mainly due to reduced appetite and lower calorie absorption. It is not a weight-loss drug but this side effect is considered beneficial in overweight patients with type 2 diabetes.

Metformin and PCOS

Polycystic ovary syndrome (PCOS) affects roughly one in ten women of reproductive age. A central feature is insulin resistance, which drives elevated insulin levels and in turn raises androgen production, disrupts ovulation, and contributes to the irregular periods and difficulty conceiving that characterise the condition. Because metformin lowers insulin levels, it has been studied as a treatment for PCOS since the 1990s.

A Cochrane systematic review of 48 trials (4,451 women) found that compared with placebo, metformin more than doubled the odds of ovulation (OR 2.55) and nearly doubled the rate of clinical pregnancy (OR 1.93).³ In women with PCOS who are not obese, metformin appears to be effective on its own. In obese women, the ovulation-inducing drug clomiphene works better than metformin alone, though combining the two improves pregnancy rates above what clomiphene achieves by itself.³

Metformin also reduces androgen levels, improves menstrual regularity, and can reduce acne and excess hair growth over months of use. It is usually taken alongside lifestyle changes rather than instead of them. Women using metformin for PCOS who are sexually active should be aware that restoring ovulation also restores the possibility of conception.

What Happens If I Miss a Dose?

Metformin works by maintaining a steady reduction in liver glucose output rather than by providing a single spike of action. A single missed dose is unlikely to cause a noticeable change in blood sugar for most people.

• Same meal: If you remember before the next meal, take the missed dose with food as usual.
• Next dose time: If you only remember when the next dose is due, skip the missed one entirely. Never take a double dose.
• Regularly forgetting: Once-daily extended-release (XR) tablets are easier to remember, and many people tolerate them better than standard immediate-release tablets. Raise this at your next review.

Lactic Acidosis: What the Evidence Actually Shows

The alert above lists lactic acidosis as a rare but serious risk, and that is accurate for people with severely reduced kidney function or other specific vulnerabilities. What it does not say is how rare it actually is in routine use, because the black box warning creates an impression that does not match the observed data.

A Cochrane review of 347 trials and cohort studies encompassing 70,490 patient-years of metformin use found zero cases of fatal or nonfatal lactic acidosis. The upper bound on true incidence, calculated by Poisson statistics, was 4.3 cases per 100,000 patient-years on metformin – similar to the 5.4 per 100,000 in the non-metformin comparison group.⁴ There was also no difference in blood lactate levels between people on metformin and those on other treatments.

This does not mean the drug is risk-free in all circumstances. The situations where it must be stopped – severely reduced kidney function (eGFR below 30), the day around a CT scan with contrast, serious acute illness, or heavy alcohol use – are real and apply because those conditions reduce metformin clearance, not because lactic acidosis is a routine occurrence. For people without these vulnerabilities taking a standard dose, lactic acidosis is not a realistic expectation; it is a reason to follow the monitoring schedule.

Pharmacist's practical notes

Long-term metformin use can gradually lower vitamin B12, so many doctors check B12 levels periodically along with kidney function (eGFR), which guides whether the medicine remains appropriate for you. Ask your doctor what schedule they have set and how results will be shared with you. Watch for symptoms worth reporting: unusual fatigue, tingling or numbness in the hands and feet (possible B12 deficiency), and — rarely but urgently — rapid deep breathing, unusual muscle pain, or severe stomach upset with weakness, which can signal a rare complication called lactic acidosis and needs emergency care.

Alcohol deserves a direct conversation with your doctor, because heavy drinking raises the risk of the rare lactic acidosis complication and can swing blood sugar. Also mention any X-ray or scan using contrast dye, since metformin is sometimes paused around such procedures, and tell your pharmacist about other diabetes medicines, diuretics, and painkillers such as NSAIDs, which can affect kidney function or blood sugar. Never adjust another diabetes medicine on your own when starting metformin.

Store metformin at room temperature away from moisture and heat, and keep it in its original labelled pack so the expiry date and product details are always visible. Diabetes medicines protect you only when taken consistently, so tie them to a stable part of your daily routine and use reminders if doses get forgotten. If side effects tempt you to stop, talk to your doctor first — there are usually options, including different formulations, that make treatment tolerable.

Tell every doctor, radiologist, and dentist about metformin before surgery, contrast scans, or any procedure involving fasting or dehydration, because the medicine is sometimes paused for a short period and the timing must come from your doctor. Bring a complete list of your medicines to every new clinic or hospital visit, and update it whenever anything changes.

In India

Metformin is among the cheapest diabetes medicines available in India as a generic, though prices still vary by brand, strength, and city. Ask your pharmacist about quality generic options rather than assuming the most expensive brand works better.

Metformin is a prescription medicine in India, widely stocked at retail and hospital pharmacies. Follow your own prescription; never start, stop, or change a dose without your doctor.

Frequently Asked Questions

References

The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.

1. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754–61. PMID 26900641 · doi:10.1210/jc.2015-3754
2. Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab. 2022;24(8):1423–8. PMID 35491956 · doi:10.1111/dom.14734
3. Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11:CD003053. PMID 29183107 · doi:10.1002/14651858.CD003053.pub6
4. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD002967. PMID 20091535 · doi:10.1002/14651858.CD002967.pub3